Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01209884 · ClinicalTrials.gov registry record
Metabolomics of Aging: Sub-study of the Healthy Elderly Active Longevity (HEAL) Study
A clinical trial, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- 14
- Enrollment target
NCT01209884: Completed study, sponsored by Scripps Translational Science Institute.
NCT01209884 is a clinical trial that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01209884 has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
This research is being done to learn more about healthy aging. We hope to learn which bodily processes or functions are important for the elderly to maintain good health. Metabolites (for example, glucose) are small molecules in our bodies that are used in all bodily reactions. Looking at their levels in healthy elderly people may help researchers find out which processes lead some people to get to disease and others to not. Metabolites are the basic building blocks for people. They are used to construct larger complexes(such as proteins), relay signals from one part of the body to another, and as a source of energy. While most people have essentially the same types of metabolites, the relative levels of these metabolites vary from one individual to another. These levels reflect the body's state of growth, development, and reproduction. An appropriate balance in metabolites is important to maintaining general health. Conditions like cancer and diabetes result in disrupted levels of metabolites that are associated with changes in bodily functions. Deviations from normal levels of metabolites can be used as a signature for disease. Researchers have discovered that a disruption in unique metabolite levels is associated with human aging. In this study we hope to learn which, if any, of these disruptions are associated with the onset of age-related disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-12 |
What the finished NCT01209884 record still lists
NCT01209884 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01209884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01209884 about?
NCT01209884 is a clinical study titled "Metabolomics of Aging: Sub-study of the Healthy Elderly Active Longevity (HEAL) Study". This research is being done to learn more about healthy aging. We hope to learn which bodily processes or functions are important for the elderly to maintain good health. Metabolites (for example, glucose) are small molecules in our bodies that are used in all bodily reactions. Looking at their leve...
What is the current status of trial NCT01209884?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2010-02. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01209884?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia